Mylan says Teva’s stake buy violates U.S. anti-trust rules

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 1 June, 2015 by The TZ Newswire Staff

Mylan says Teva’s stake buy violates U.S. anti-trust rules

Mylan NV said Teva Pharmaceutical Industries Ltd , which has made an unsolicited offer for the company, violated U.S. anti-trust rules by acquiring a stake. Teva disclosed a 1.35 percent stake in Mylan …

See also
- Next Article Intel to buy Altera for $16.7 billion in its biggest deal ever
- Previous Article U.S. hotel business poised for good years, leaders say
Editorial Calender

June 2015

M T W T F S S

1 2 3 4 5 6 7

8 9 10 11 12 13 14

15 16 17 18 19 20 21

22 23 24 25 26 27 28

29 30

« May Jul »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 1 June, 2015 by The TZ Newswire Staff

Mylan says Teva’s stake buy violates U.S. anti-trust rules

See also

Editorial Calender

Recent Tags